Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > AGM

<< Previous

Bullboard Posts

Next >>

Comment by Jaro1977on Jun 29, 2022 12:31pm

220 Views

Post# 34790805

RE:RE:RE:RE:RE:RE:RE:RE:AGM

They are focused on finishing the NMIBC phase 2 and BTD, AA
It's possible that they could commercialize 2023 while the phase 2 is still going on towards patients 41-125 with good data and talks with FDA
I do not recall the exact words but it seems that they would look at a partnership, JV if it were to come along but that they really want to finish the trail and showcase excellent results. They know what they have and it could be so much more than what is is at now once it's proven.

<< Previous

Bullboard Posts

Next >>

A potential breakthrough in spinal cord and optic nerve injury treatment